Previous chemotherapy influences the symptom experience and quality of life of women with breast cancer prior to radiation therapy

Cancer Nursing

Volumn 35, Issue 3, 2012, Pages 167-177

  Hofsø, Kristin ^a   Miaskowski, Christine ^b   Bjordal, Kristin ^c   Cooper, Bruce A ^b   Rustøen, Tone ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Breast cancer; MSAS; Quality of life; Radiation therapy; Symptoms

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ANAMNESIS; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL FEATURE; COMORBIDITY; DISEASE SEVERITY; DISTRESS SYNDROME; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE;

AGED; ANXIETY; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FATIGUE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; NURSING METHODOLOGY RESEARCH; PAIN; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SLEEP INITIATION AND MAINTENANCE DISORDERS; STRESS, PSYCHOLOGICAL; SWEATING; TREATMENT OUTCOME;

EID: 84860340398     PISSN: 0162220X     EISSN: 15389804     Source Type: Journal    
DOI: 10.1097/NCC.0b013e31821f5eb5     Document Type: Article

References (57)

1. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366(9503):2087Y2106. (Pubitemid 41797643)
2. Van de SJ, Vinh-Hung V, Cutuli B, Storme G. Adjuvant radiotherapy for breast cancer: effects of longer follow-up. Radiother Oncol. 2004;72(1):35Y43. (Pubitemid 38952857)
3. Norwegian Breast Cancer Group (NBCG). 2010. http://www.nbcg.no/ nbcg.blaaboka.html. Accessed March 12, 2010.
4. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol. 2005;16(10):1569Y1583. (Pubitemid 41511089)
5. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365(9472):1687Y1717.
6. Byar KL, Berger AM, Bakken SL, Cetak MA. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncol Nurs Forum. 2006;33(1):E18YE26.
7. Hack TF, KwanWB, Thomas-Maclean RL, et al. Predictors of arm morbidity following breast cancer surgery. Psychooncology. 2010;19(11):1205Y1212.
8. Knobf MT, Sun Y. A longitudinal study of symptoms and self-care activities in women treated with primary radiotherapy for breast cancer. Cancer Nurs. 2005;28(3):210Y218. (Pubitemid 40734540)
9. Kaya T, Karatepe AG, Gunaydn R, Yetis H, Uslu A. Disability and healthrelated quality of life after breast cancer surgery: relation to impairments. South Med J. 2010;103(1):37Y41.
10. Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A. Long-term morbidity of patients wiThearly breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol. 2006;93(2):109Y119. (Pubitemid 43235256)
11. Ganz PA, Kwan L, Stanton AL, et al. Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst. 2004;96(5):376Y387. (Pubitemid 38351299)
12. Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18(4):743Y753. (Pubitemid 30106604)
13. Tchen N, Juffs HG, Downie FP, et al. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol. 2003;21(22):4175Y4183. (Pubitemid 46606186)
14. Jacobsen PB, Hann DM, Azzarello LM, Horton J, Balducci L, Lyman GH. Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage. 1999;18(4):233Y242. (Pubitemid 29469701)
15. Mortimer JE. Managing the toxicities of the aromatase inhibitors. Curr Opin Obstet Gynecol. 2010;22(1):56Y60.
16. Cleeland CS. Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr. 2007;(37):16Y21.
17. Dodd MJ, Cho MH, Cooper BA, Miaskowski C. The effect of symptom clusters on functional status and quality of life in women with breast cancer. Eur J Oncol Nurs. 2010;14(2):101Y110.
18. Esther Kim JE, Dodd MJ, Aouizerat BE, Jahan T, Miaskowski C. A review of the prevalence and impact of multiple symptoms in oncology patients. J Pain Symptom Manage. 2009;37(4):715Y736.
19. Chen X, Zheng Y, Zheng W, et al. Prevalence of depression and its related factors among Chinese women with breast cancer. Acta Oncol. 2009;48(8):1128Y1136.
20. Gwede CK, Small BJ, Munster PN, Andrykowski MA, Jacobsen PB. Exploring the differential experience of breast cancer treatment-related symptoms: a cluster analytic approach. Support Care Cancer. 2008;16(8):925Y933.
21. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol. 1984;2(3):187Y193. (Pubitemid 14138407)
22. SanghaO, Stucki G, LiangMH, Fossel AH, Katz JN. The Self-administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49(2):156Y163. (Pubitemid 36418272)
23. Portenoy RK, Thaler HT, Kornblith AB, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluat ion of symptom prevalence, characteristics and distress. Eur J Cancer. 1994;30A(9):1326Y1336. (Pubitemid 24322071)
24. Ware JE, Kosinski M, Keller SD. A 12-item, short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;3:220Y223.
25. Humphreys J, Lee KA, Carrieri-Kohlman V, et al. Theory of symptom management. In: Smith MJ, Liehr PR, eds. Middle Range Theory for Nursing. 2nd ed. New York: Springer Publisher Company; 2008:145Y158.
26. Larson PJ, Carrieri-Kohlman V, Dodd MJ, et al. A model for symptom management. Image J Nurs Scholarsh. 1994;26:272Y276.
27. Oncolex. 2010. http://www.oncolex.no/en/Bryst/Bakgrunn/Stadier.aspx. Accessed May 29, 2010.
28. Breast Cancer Org. 2010. http://www.breastcancer.org/symptoms/types/ dcis/diagnosis.jsp. Accessed May 29, 2010.
29. Mapi Research Institute. Mapi Institute Linguistic Validation. 2004. www mapi-trust com. Accessed April 14, 2010.
30. Valeberg BT, Miaskowski C, Hanestad BR, Bjordal K, Paul S, Rustoen T. Demographic, clinical, and pain characteristics are associated with average pain severity groups in a sample of oncology outpatients. J Pain. 2008; 9(10):873Y882.
31. Ljosaa TM, Rustoen T, Mork C, et al. Skin pain and discomfort in psoriasis: an exploratory study of symptom prevalence and characteristics. Acta Derm Venereol. 2010;90(1):39Y45.
32. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer. 1984;53(9):2002Y2007.
33. Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51(11):1171Y1178. (Pubitemid 28527173)
34. Miaskowski C, Cooper BA, Paul SM, et al. Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum. 2006;33(5):E79YE89.
35. Pud D, Ben AS, Cooper BA, et al. The symptom experience of oncology outpatients has a different impact on quality-of-life outcomes. J Pain Symptom Manage. 2008;35(2):162Y170.
36. Loge JH, Kaasa S, Hjermstad MJ, Kvien TK. Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol. 1998;51(11):1069Y1076. (Pubitemid 28527162)
37. Ware JE, Kosinski M, Keller SD. How to Score the SF-12 Physical and Mental Summary Scales. Boston, MA: New England Medical Center, Health Institute; 1995.
38. Benjamini Y, Hochberg Y. Controlling the false discovery rateVa practical and powerful approach to multiple testing. J R Stat Ser B Method. 1995; 57(1):289Y300.
39. Hemphill JF. Interpreting the magnitudes of correlation coefficients. Am Psychol. 2003;58(1):78Y79. (Pubitemid 37170640)
40. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: Wiley; 2000.
41. Mittlbock M, Schemper M. Explained variation for logistic regression. Stat Med. 1996;15(19):1987Y1997. (Pubitemid 26332292)
42. McFadden D. The measurement of urban travel demand. J Public Econ. 1974;3(4):303Y328.
43. Menard S. Coefficients of determination for multiple logistic regression. Am Stat. 2000;54(1):17Y24.
44. KimE, Jahan T, Aouizerat BE, et al. Changes in symptom clusters in patients undergoing radiation therapy. Support Care Cancer. 2009;17(11): 1383Y1391.
45. Harding R, Selman L, Agupio G, et al. The prevalence and burden of symptoms amongst cancer patients attending palliative care in two African countries [published online ahead of print September 2010]. Eur J Cancer. 2011;47(1):51Y56.
46. Portenoy RK, Thaler HT, Kornblith AB, et al. Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res. 1994;3(3):183Y189. (Pubitemid 24253426)
47. Molassiotis A, Zheng Y, ton-Cardew L, Swindell R, Brunton L. Symptoms experienced by cancer patients during the first year from diagnosis: patient and informal caregiver ratings and agreement. Palliat Support Care. 2010; 8(3):313Y324.
48. Stiegelis HE, Ranchor AV, Sanderman R. Psychological functioning in cancer patients treated with radiotherapy. Patient Educ Couns. 2004;52(2):131Y141. (Pubitemid 38169224)
49. Molassiotis A, Wengstrom Y, Kearney N. Symptom cluster patterns during the first year after diagnosis with cancer. J Pain Symptom Manage. 2010;39(5):847Y858.
50. Bromberger JT, Meyer PM, Kravitz HM, et al. Psychologic distress and natural menopause: a multiethnic community study. Am J Public Health. 2001;91(9):1435Y1442. (Pubitemid 32803329)
51. Kautio AL, Haanpaa M, Kautiainen H, Kalso E, Saarto T. Burden of chemotherapy-induced neuropathyVa cross-sectional study [published online ahead of print]. Support Care Cancer. 2010.
52. Spichiger E, Muller-Frohlich C, Denhaerynck K, Stoll H, Hantikainen V, Dodd M. Symptom prevalence and changes of symptoms over ten days in hospitalized patients with advanced cancer: a descriptive study. Eur J Oncol Nurs. 2010;15(2):95Y102.
53. Clark J, Cunningham M, McMillan S, Vena C, Parker K. Sleep-wake disturbances in people with cancer part II: evaluating the evidence for clinical decision making. Oncol Nurs Forum. 2004;31(4):747Y771.
54. Yoon J, Malin JL, Tao ML, et al. Symptoms after breast cancer treatment: are they influenced by patient characteristics? Breast Cancer Res Treat. 2008;108(2):153Y165. (Pubitemid 351311365)
55. Kenefick AL. Patterns of symptom distress in older women after surgical treatment for breast cancer. Oncol Nurs Forum. 2006;33(2):327Y335. (Pubitemid 43672486)
56. Stanton AL, Bernaards CA, Ganz PA. The BCPT symptom scales: A measure of physical symptoms for women diagnosed wiThor at risk for breast cancer. J Natl Cancer Inst. 2005;97(6):448Y456. (Pubitemid 40528608)
57. Hopwood P, Haviland JS, Sumo G, Mills J, Bliss JM, Yarnold JR. Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials. Lancet Oncol. 2010;11(3):231Y240.